Lv41
420 积分 2023-02-17 加入
Dealing with and Defining Abnormalities in Laboratory Data
2小时前
待确认
Aligning Treatment Policy Estimands and Estimators—A Simulation Study in Alzheimer’s Disease
4个月前
已完结
Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation
4个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
4个月前
已完结
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints
4个月前
已完结
Estimating a treatment effect in survival studies in which patients switch treatment
6个月前
已完结
Adjusting overall survival for treatment switches: commonly used methods and practical application
6个月前
已完结
Key multiplicity issues in clinical drug development
1年前
已完结
Traditional multiplicity adjustment methods in clinical trials
1年前
已完结
TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES
1年前
已完结
皖公网安备34019202002308
